If you've been paying attention to product safety research over the last few years, you've probably seen the headlines: PFAS chemicals cause cancer. But the details matter enormously here - which PFAS, which cancers, at what exposures, for whom, and through what mechanisms. The research is real and the risks are significant, but the picture is more precise than most media coverage suggests.
Let me walk you through what we actually know.
What IARC Said in December 2023
In November 2023, the International Agency for Research on Cancer (IARC) - the WHO's cancer research arm and the global gold standard for carcinogenicity evaluation - published Volume 135 of its Monographs series, which evaluated PFOA and PFOS for carcinogenicity.
The findings were significant:
- PFOA: Group 1 - Carcinogenic to Humans. This is the highest classification IARC issues. It means there is sufficient evidence from human epidemiological studies showing a causal link between PFOA exposure and cancer. The same group as tobacco smoke, asbestos, and benzene.
- PFOS: Group 2B - Possibly Carcinogenic to Humans. This classification indicates limited evidence in humans and strong mechanistic evidence. The Group 2B designation reflects that the human data is not yet sufficient to confirm causality, but the mechanistic case is compelling.
The IARC working group based its PFOA determination on several lines of converging evidence: limited but meaningful data in humans for kidney and testicular cancer, sufficient evidence in experimental animals across multiple tumor types, and strong mechanistic evidence that PFOA exhibits key characteristics of carcinogens in exposed humans - including epigenetic alterations and immunosuppression.
This is not the first time PFOA has been linked to cancer. But the Group 1 classification represents the scientific community's consensus that the causal evidence is now strong enough to move from "probable" to "confirmed."
The C8 Health Project: The Foundation of What We Know
Most of what we understand about PFOA and cancer in real-world human populations comes from a single extraordinary data source: the C8 Health Project.
The project originated from attorney Rob Bilott's 1999 lawsuit against DuPont, filed on behalf of a farmer whose cattle were dying near the company's Washington Works plant in Parkersburg, West Virginia. The plant had been manufacturing PTFE (Teflon) using PFOA as a processing aid since the early 1950s - and had been depositing PFOA waste in ways that contaminated drinking water for surrounding communities in both West Virginia and Ohio.
The 2004 settlement created the C8 Science Panel - an independent team of epidemiologists tasked with enrolling 69,000+ area residents, measuring their PFOA serum levels, and tracking their health outcomes for years. This is the largest prospective community health study ever conducted on a single chemical.
Between 2011 and 2012, the C8 Science Panel delivered its findings. PFOA was found to have a "probable link" with six health outcomes:
- 1.Kidney cancer (renal cell carcinoma)
- 2.Testicular cancer
- 3.Ulcerative colitis
- 4.Thyroid disease
- 5.High cholesterol (hypercholesterolemia)
- 6.Pregnancy-induced hypertension (preeclampsia)
Those "probable link" findings - which carried legal weight in the DuPont litigation and ultimately led to more than $671 million in settlements to approximately 3,500 plaintiffs - have since been reinforced by multiple independent cohort studies and were central to IARC's 2023 Group 1 determination.
Cancer by Cancer: What the Evidence Shows